1514888-56-2 (S1p receptor agonist 1,S1p Receptor agonist 1)

S1p receptor agonist 1;

S1p receptor agonist 1;YUN88562;1-{2-Fluoro-4-[5-(4-isobutyl-phenyl)-[1,2,4]oxadiazol-3-yl]-benzyl}-azetidine-3-carboxylic acid;S1p-receptor-agonist-1;S1P-agonist-1;BCP31070;FC1=C(CN2CC(C2)C(=O)O)C=CC(=C1)C1=NOC(=N1)C1=CC=C(C=C1)CC(C)C;1-(2-fluoro-4-(5-(4-isobutylphenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid;GLXC-10702;1-[(2-FLUORO-4-{5-[4-(2-METHYLPROPYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}PHENYL)METHYL]AZETIDINE-3-CARBOXYLIC ACID;1-((2-fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methyl)azetidine-3-carboxylic acid;CS-6254;compound 2 (WO2015039587A1);1-[[2-fluoro-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]azetidine-3-carboxylic acid;UNII-J055N05PGQ;F85514;SCHEMBL16591177;1-[(2-fluoro-4-{5-[4-(2-methylpropyl)phenyl]-1,2,4- oxadiazol-3-yl}phenyl)methyl]azetidine-3-carboxylic acid;AR-507630;DA-77618;AR507630;7I4;MS-27049;compound 2 [WO2015039587A1];1-((2-Fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methyl)-3-azetidine carboxylic acid;J055N05PGQ;3-Azetidinecarboxylic acid, 1-((2-fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methyl)-;HY-101265;AKOS037515529;GTPL12098;1514888-56-2;1-[[2-fluoranyl-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]azetidine-3-carboxylic acid;1-((2-Fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4- oxadiazol-3-yl)phenyl)methyl)azetidine-3-carboxylic acid;Icanbelimod;Icanbelimod [INN];CHEMBL4097139;EX-A2486;

MFCD30738002

YBIFMTGYWXNIRZ-UHFFFAOYSA-N

1S/C23H24FN3O3/c1-14(2)9-15-3-5-16(6-4-15)22-25-21(26-30-22)17-7-8-18(20(24)10-17)11-27-12-19(13-27)23(28)29/h3-8,10,14,19H,9,11-13H2,1-2H3,(H,28,29)

FC1C([H])=C(C2=NOC(C3C([H])=C([H])C(=C([H])C=3[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=N2)C([H])=C([H])C=1C([H])([H])N1C([H])([H])C([H])(C(=O)O[H])C1([H])[H]